Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers

Byeongmoon Jeong; You Han Bae; Sung Wan Kim

doi:10.1016/S0168-3659(99)00194-7

Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers

Byeongmoon Jeong, You Han Bae, Sung Wan Kim

Department of Chemistry & Nanoscience

Research output: Contribution to journal › Article › peer-review

592 Scopus citations

Abstract

An aqueous solution of newly developed low-molecular-weight PEG-PLGA-PEG triblock copolymers with a specific composition is a free flowing sol at room temperature but becomes a gel at body temperature. Two model drugs, ketoprofen and spironolatone, which have different hydrophobicities, were released from the PEG-PLGA-PEG triblock copolymer hydrogel formed in situ by injecting the solutions into a 37°C aqueous environment. Ketoprofen (a model hydrophilic drug) was released over 2 weeks with a first-order release profile, while spironolactone (a model hydrophobic drug) was released over 2 months with an S-shaped release profile. The release profiles were simulated by models considering degradation and diffusion, and were better described by a model assuming a core-shell structure of the gel.

Original language	English
Pages (from-to)	155-163
Number of pages	9
Journal	Journal of Controlled Release
Volume	63
Issue number	1-2
DOIs	https://doi.org/10.1016/S0168-3659(99)00194-7
State	Published - 3 Jan 2000

Bibliographical note

Funding Information:
This work was supported by the University of Utah Research Foundation.

Keywords

Biodegradable hydrogel
Drug release model
Injectable formulation
Sol-gel transition, In situ gel

Access to Document

10.1016/S0168-3659(99)00194-7

Cite this

@article{ef1ab68193f14bc185ad8c91d7b2ad8f,

title = "Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers",

abstract = "An aqueous solution of newly developed low-molecular-weight PEG-PLGA-PEG triblock copolymers with a specific composition is a free flowing sol at room temperature but becomes a gel at body temperature. Two model drugs, ketoprofen and spironolatone, which have different hydrophobicities, were released from the PEG-PLGA-PEG triblock copolymer hydrogel formed in situ by injecting the solutions into a 37°C aqueous environment. Ketoprofen (a model hydrophilic drug) was released over 2 weeks with a first-order release profile, while spironolactone (a model hydrophobic drug) was released over 2 months with an S-shaped release profile. The release profiles were simulated by models considering degradation and diffusion, and were better described by a model assuming a core-shell structure of the gel.",

keywords = "Biodegradable hydrogel, Drug release model, Injectable formulation, Sol-gel transition, In situ gel",

author = "Byeongmoon Jeong and Bae, {You Han} and Kim, {Sung Wan}",

note = "Funding Information: This work was supported by the University of Utah Research Foundation.",

year = "2000",

month = jan,

day = "3",

doi = "10.1016/S0168-3659(99)00194-7",

language = "English",

volume = "63",

pages = "155--163",

journal = "Journal of Controlled Release",

issn = "0168-3659",

publisher = "Elsevier",

number = "1-2",

}

TY - JOUR

T1 - Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers

AU - Jeong, Byeongmoon

AU - Bae, You Han

AU - Kim, Sung Wan

N1 - Funding Information: This work was supported by the University of Utah Research Foundation.

PY - 2000/1/3

Y1 - 2000/1/3

N2 - An aqueous solution of newly developed low-molecular-weight PEG-PLGA-PEG triblock copolymers with a specific composition is a free flowing sol at room temperature but becomes a gel at body temperature. Two model drugs, ketoprofen and spironolatone, which have different hydrophobicities, were released from the PEG-PLGA-PEG triblock copolymer hydrogel formed in situ by injecting the solutions into a 37°C aqueous environment. Ketoprofen (a model hydrophilic drug) was released over 2 weeks with a first-order release profile, while spironolactone (a model hydrophobic drug) was released over 2 months with an S-shaped release profile. The release profiles were simulated by models considering degradation and diffusion, and were better described by a model assuming a core-shell structure of the gel.

AB - An aqueous solution of newly developed low-molecular-weight PEG-PLGA-PEG triblock copolymers with a specific composition is a free flowing sol at room temperature but becomes a gel at body temperature. Two model drugs, ketoprofen and spironolatone, which have different hydrophobicities, were released from the PEG-PLGA-PEG triblock copolymer hydrogel formed in situ by injecting the solutions into a 37°C aqueous environment. Ketoprofen (a model hydrophilic drug) was released over 2 weeks with a first-order release profile, while spironolactone (a model hydrophobic drug) was released over 2 months with an S-shaped release profile. The release profiles were simulated by models considering degradation and diffusion, and were better described by a model assuming a core-shell structure of the gel.

KW - Biodegradable hydrogel

KW - Drug release model

KW - Injectable formulation

KW - Sol-gel transition, In situ gel

UR - http://www.scopus.com/inward/record.url?scp=0142210489&partnerID=8YFLogxK

U2 - 10.1016/S0168-3659(99)00194-7

DO - 10.1016/S0168-3659(99)00194-7

M3 - Article

C2 - 10640589

AN - SCOPUS:0142210489

SN - 0168-3659

VL - 63

SP - 155

EP - 163

JO - Journal of Controlled Release

JF - Journal of Controlled Release

IS - 1-2

ER -

Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this